GENOMADIX UK
Active
Sponsor Information
| Organisation Name | GENOMADIX UK |
|---|---|
| Location | London |
| Visa Routes | Global Business Mobility: UK Expansion Worker |
| Sponsor Rating |
A-rated sponsors have demonstrated full compliance with UK immigration rules. |
| Incorporated | 20 March 2024 |
| Last Verified | 11 August 2026 |
Companies House Data
| Company Number | FC041785 |
|---|---|
| Company Status | Active |
| Industry (SIC Codes) | Not specified |
Description
1 HOUR CYP2C19 GENOTYPING FDA 510(k)-Cleared, Health Canada MDL, and CE Marked Rapid CYP2C19 Genotyping can aid in the implementation of genotype-guided dual antiplatelet therapy (DAPT)1 U.S. AHA/ASA guidelines2 recommend dual antiplatelet therapy (DAPT) within 12-24 hours of first stroke or TIA to prevent recurrent stroke for minor stroke or high-risk TIA. Clinical Pharmacogenetic Implementation […]